Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: May 31, 2024
Epidemiological
models—which
help
us
understand
and
forecast
the
spread
of
infectious
disease—can
be
valuable
tools
for
public
health.
However,
barriers
exist
that
can
make
it
difficult
to
employ
epidemiological
models
routinely
within
repertoire
health
planning.
These
include
technical
challenges
associated
with
constructing
models,
in
obtaining
appropriate
data
model
parameterization,
problems
clear
communication
modeling
outputs
uncertainty.
To
learn
about
unique
opportunities
state
Arizona,
we
gathered
a
diverse
set
48
stakeholders
day-and-a-half
forum.
Our
research
group
was
motivated
specifically
by
our
work
building
software
health-relevant
earnest
desire
collaborate
closely
ensure
are
practical
useful
face
evolving
needs.
Here
outline
planning
structure
forum,
highlight
as
case
study
some
lessons
learned
from
breakout
discussions.
While
implementing
health,
there
is
also
keen
interest
doing
so
across
sectors
State
Local
government,
although
issues
equal
fair
access
knowledge
technologies
remain
key
future
development.
We
found
this
forum
relationships
informing
development,
plan
continue
such
meetings
annually
create
continual
feedback
loop
between
academic
molders
practitioners.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: July 26, 2024
Accurate
forecasts
can
enable
more
effective
public
health
responses
during
seasonal
influenza
epidemics.
For
the
2021-22
and
2022-23
seasons,
26
forecasting
teams
provided
national
jurisdiction-specific
probabilistic
predictions
of
weekly
confirmed
hospital
admissions
for
one-to-four
weeks
ahead.
Forecast
skill
is
evaluated
using
Weighted
Interval
Score
(WIS),
relative
WIS,
coverage.
Six
out
23
models
outperform
baseline
model
across
forecast
locations
in
12
18
2022-23.
Averaging
all
targets,
FluSight
ensemble
2
Epidemics,
Journal Year:
2024,
Volume and Issue:
47, P. 100757 - 100757
Published: March 5, 2024
The
Scenario
Modeling
Hub
(SMH)
initiative
provides
projections
of
potential
epidemic
scenarios
in
the
United
States
(US)
by
using
a
multi-model
approach.
Our
contribution
to
SMH
is
generated
multiscale
model
that
combines
global
metapopulation
modeling
approach
(GLEAM)
with
local
and
mobility
US
(LEAM-US),
first
introduced
here.
LEAM-US
consists
3142
subpopulations
each
representing
single
county
across
50
states
District
Columbia,
enabling
us
project
state
national
trajectories
COVID-19
cases,
hospitalizations,
deaths
under
different
scenarios.
age-structured,
multi-strain.
It
integrates
data
on
vaccine
administration,
human
mobility,
non-pharmaceutical
interventions.
contributed
all
17
rounds
SMH,
allows
for
mechanistic
characterization
spatio-temporal
heterogeneities
observed
during
pandemic.
Here
we
describe
mathematical
computational
structure
underpinning
our
model,
present
as
case
study
results
concerning
emergence
SARS-CoV-2
Alpha
variant
(lineage
designation
B.1.1.7).
findings
reveal
considerable
spatial
temporal
heterogeneity
introduction
diffusion
variant,
both
at
level
individual
combined
statistical
areas,
it
competes
against
ancestral
lineage.
We
discuss
key
factors
driving
time
required
rise
dominance
within
population,
quantify
significant
impact
had
effective
reproduction
number
level.
Overall,
show
able
capture
complexity
pandemic
response
US.
Epidemics,
Journal Year:
2024,
Volume and Issue:
46, P. 100746 - 100746
Published: Feb. 10, 2024
Throughout
the
COVID-19
pandemic,
changes
in
policy,
shifts
behavior,
and
emergence
of
new
SARS-CoV-2
variants
spurred
multiple
waves
transmission.
Accurate
assessments
changing
risks
were
vital
for
ensuring
adequate
healthcare
capacity,
designing
mitigation
strategies,
communicating
effectively
with
public.
Here,
we
introduce
a
model
transmission
vaccination
that
provided
rapid
reliable
projections
as
BA.1,
BA.4
BA.5
emerged
spread
across
US.
For
example,
our
three-week
ahead
national
projection
early
2021
peak
hospitalizations
was
only
one
day
later
11.6-13.3%
higher
than
actual
peak,
while
projected
mortality
two
days
earlier
0.22-4.7%
reported.
We
track
population-level
immunity
from
prior
infections
terms
percent
reduction
overall
susceptibility
relative
to
completely
naive
population.
As
October
1,
2022,
estimate
US
population
had
36.52%
BA.4/BA.5
variants,
61.8%,
15.06%,
23.54%
attributable
infections,
primary
series
vaccination,
booster
respectively.
retrospectively
potential
impact
expanding
coverage
starting
on
July
15,
found
five-fold
increase
weekly
boosting
rates
would
have
resulted
70%
people
over
65
vaccinated
by
Oct
10,
2022
averted
25,000
(95%
CI:
14,400-35,700)
deaths
during
surge.
Our
provides
coherent
variables
tracking
increasingly
complex
landscape
vaccines
enables
robust
simulations
plausible
scenarios
novel
COVID
variants.
Epidemics,
Journal Year:
2024,
Volume and Issue:
48, P. 100784 - 100784
Published: July 31, 2024
The
COVID-19
pandemic
demonstrated
the
key
role
that
epidemiology
and
modelling
play
in
analysing
infectious
threats
supporting
decision
making
real-time.
Motivated
by
unprecedented
volume
breadth
of
data
generated
during
pandemic,
we
review
modern
opportunities
for
analysis
to
address
questions
emerge
a
major
epidemic.
Following
broad
chronology
insights
required
-
from
understanding
initial
dynamics
retrospective
evaluation
interventions,
describe
theoretical
foundations
each
approach
underlying
intuition.
Through
series
case
studies,
illustrate
real
life
applications,
discuss
implications
future
work.
Infectious Disease Modelling,
Journal Year:
2024,
Volume and Issue:
9(2), P. 501 - 518
Published: Feb. 23, 2024
In
July
2023,
the
Center
of
Excellence
in
Respiratory
Pathogens
organized
a
two-day
workshop
on
infectious
diseases
modelling
and
lessons
learnt
from
Covid-19
pandemic.
This
report
summarizes
rich
discussions
that
occurred
during
workshop.
The
participants
discussed
multisource
data
integration
highlighted
benefits
combining
traditional
surveillance
with
more
novel
sources
like
mobility
data,
social
media,
wastewater
monitoring.
Significant
advancements
were
noted
development
predictive
models,
examples
various
countries
showcasing
use
machine
learning
artificial
intelligence
detecting
monitoring
disease
trends.
role
open
collaboration
between
stakeholders
was
stressed,
advocating
for
continuation
such
partnerships
beyond
A
major
gap
identified
absence
common
international
framework
sharing,
which
is
crucial
global
pandemic
preparedness.
Overall,
underscored
need
robust,
adaptable
frameworks
different
across
sectors,
as
key
elements
enhancing
future
response
Epidemics,
Journal Year:
2023,
Volume and Issue:
46, P. 100738 - 100738
Published: Dec. 29, 2023
Between
December
2020
and
April
2023,
the
COVID-19
Scenario
Modeling
Hub
(SMH)
generated
operational
multi-month
projections
of
burden
in
US
to
guide
pandemic
planning
decision-making
context
high
uncertainty.
This
effort
was
born
out
an
attempt
coordinate,
synthesize
effectively
use
unprecedented
amount
predictive
modeling
that
emerged
throughout
pandemic.
Here
we
describe
history
this
massive
collective
research
effort,
process
convening
maintaining
open
hub
active
over
multiple
years,
provide
a
blueprint
for
future
efforts.
We
detail
generating
17
rounds
scenarios
at
different
stages
pandemic,
disseminating
results
public
health
community
lay
public.
also
highlight
how
SMH
expanded
generate
influenza
during
2022-23
season.
identify
key
impacts
on
draw
lessons
improve
collaborative
efforts,
scenario
projections,
interface
between
models
policy.
Epidemics,
Journal Year:
2024,
Volume and Issue:
46, P. 100748 - 100748
Published: Feb. 8, 2024
Throughout
the
COVID-19
pandemic,
scenario
modeling
played
a
crucial
role
in
shaping
decision-making
process
of
public
health
policies.
Unlike
forecasts,
projections
rely
on
specific
assumptions
about
future
that
consider
different
plausible
states-of-the-world
may
or
not
realize
and
depend
policy
interventions,
unpredictable
changes
epidemic
outlook,
etc.
As
consequence,
long-term
require
evaluation
criteria
than
ones
used
for
traditional
short-term
forecasts.
Here,
we
propose
novel
ensemble
procedure
assessing
pandemic
using
results
Scenario
Modeling
Hub
(SMH)
US.
By
defining
"scenario
ensemble"
each
model
models,
termed
"Ensemble2",
provide
synthesis
potential
outcomes,
which
use
to
assess
projections'
performance,
bypassing
identification
most
scenario.
We
find
overall
Ensemble2
models
are
well-calibrated
better
performance
individual
models.
The
accounts
full
range
outcomes
highlights
importance
design
effective
communication.
ensembling
approach
can
be
extended
any
strategy,
with
refinements
including
weighting
scenarios
allowing
evolve
over
time.
Epidemics,
Journal Year:
2024,
Volume and Issue:
47, P. 100767 - 100767
Published: April 17, 2024
Mathematical
models
are
useful
for
public
health
planning
and
response
to
infectious
disease
threats.
However,
different
can
provide
differing
results,
which
hamper
decision
making
if
not
synthesized
appropriately.
To
address
this
challenge,
multi-model
hubs
convene
independent
modeling
groups
generate
ensembles,
known
more
accurate
predictions
of
future
outcomes.
Yet,
these
resource
intensive,
how
many
sufficient
in
a
hub
is
known.
Here,
we
compare
the
benefit
from
multiple
contexts:
(1)
settings
that
depend
on
quantitative
outcomes
(e.g.,
hospital
capacity
planning),
where
assessments
benefits
ensembles
have
largely
focused;
(2)
decisions
require
ranking
alternative
epidemic
scenarios
comparing
under
possible
interventions
biological
uncertainties).
We
develop
mathematical
framework
mimic
prediction
setting,
use
quantify
frequently
agree.
further
explore
agreement
using
real-world,
empirical
data
14
rounds
U.S.
COVID-19
Scenario
Modeling
Hub
projections.
Our
results
suggest
value
could
be
contexts,
only
few
available,
focusing
rank
robust
than
Although
additional
exploration
number
contexts
still
needed,
our
indicate
it
may
identify
rely
fewer
models,
finding
inform
resources
during
crises.
PLoS Medicine,
Journal Year:
2024,
Volume and Issue:
21(4), P. e1004387 - e1004387
Published: April 17, 2024
Coronavirus
Disease
2019
(COVID-19)
continues
to
cause
significant
hospitalizations
and
deaths
in
the
United
States.
Its
continued
burden
impact
of
annually
reformulated
vaccines
remain
unclear.
Here,
we
present
projections
COVID-19
States
for
next
2
years
under
plausible
assumptions
about
immune
escape
(20%
per
year
50%
year)
3
possible
CDC
recommendations
use
(no
recommendation,
vaccination
those
aged
65
over,
all
eligible
age
groups
based
on
FDA
approval).